Hrt Financial LP Iovance Biotherapeutics, Inc. Transaction History

Hrt Financial LP

$15.6 Billion
Q1 2024

A detailed history of Hrt Financial LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 296,174 shares of IOVA stock, worth $2.38 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

296,174

Previous 294,763 0.48%

Holding current value

$2.38 Million

Previous $2.4 Million 83.18%

% of portfolio

0.03%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $10,709 - $24,650	1,411 Added 0.48%	296,174 $4.39 Million
Q4 2023 Feb 09, 2024	BUY	$3.3 - $8.89 $972,717 - $2.62 Million	294,763 New	294,763 $2.4 Million
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $1.48 Million - $2.2 Million	267,997 New	267,997 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $1.33 Million - $1.83 Million	139,467 New	139,467 $1.34 Million
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $1.36 Million - $3.9 Million	-212,974 Closed	0 $0

Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $1.83 Million - $2.82 Million	147,460 Added 225.08%	212,974 $3.55 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $102,444 - $171,029	-6,190 Reduced 8.63%	65,514 $1.25 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $1.46 Million - $1.91 Million	71,704 New	71,704 $1.77 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $2.32 Million - $4.26 Million	-80,965 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $2.27 Million - $4.07 Million	80,965 New	80,965 $3.76 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $3.11 Million - $4.07 Million	-112,098 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $3.05 Million - $4.6 Million	112,098 New	112,098 $3.08 Million

Others Institutions Holding IOVA

# of Institutions

303

Shares Held

221M

Call Options Held

3.05M

Put Options Held

1.6M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.27B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account